Rx Industry Supports “Reasonable” Tiered Copays, PhRMA CEO Says
The pharmaceutical industry agrees that "reasonable" tiering of prescription drug copays is an appropriate way to encourage cost-consciousness by consumers, Pharmaceutical Research & Manufacturers of America CEO Alan Holmer told the Pharmaceutical Compliance Congress Nov. 16 in Washington, D.C